Clinical Compendia Analysis Leads to Better Payer Formulary Positioning
Industry
Pharmaceutical Manufacturer
Problem
A brand pharmaceutical manufacturer’s drug had a competitor that launched a product with the same active ingredient. Although both products had similar indications, our brand manufacturer client’s product had an additional indication beyond that of their competitor. Our client wanted to ensure that healthcare practitioners were clearly able to differentiate the products for prescribing and wanted payers to be aware of these differences for formulary and coverage purposes.
PHSL Solutions
PHSL performed a review of how both products were listed across the major clinical drug compendia. PHSL identified that the competitor’s product was incorrectly listed as being indicated for our client’s unique indication in one of the leading compendia. It was also discovered that a payer was referencing this compendium listing as a justification for coverage and formulary decisions.
Results
PHSL was able to work with our client to have their unique indication removed from the competitor product’s clinical compendia listing. The manufacturer was able to use this new compendium change to contact the payer in question and have their own product once again preferred over their competitor’s drug.